Grad 3 eller grad 4 avvikelser av trombocyter, inklusive trombocytopeni observerades hos 14% av de patienter som fick TMZ. ###>Grade 3 or Grade 4 thrombocyte abnormalities, including thrombocytopenic events were observed in 14% of the patients who received TMZ.